Core Laboratories Inc. ("Core," "Core Lab," or the "Company") reported first quarter 2026 revenue of $121,800,000. Core's operating income was $1,900,000, with a loss per diluted share of $0.02, all ...
From PCR to next-gen sequencing, molecular diagnostics are revolutionizing how we detect infectious diseases—offering faster, more sensitive, and more precise results than traditional cultures. These ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results